Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Genus Bupleurum: a review of its phytochemistry, pharmacology and modes of action

Identifieur interne : 001660 ( Main/Exploration ); précédent : 001659; suivant : 001661

Genus Bupleurum: a review of its phytochemistry, pharmacology and modes of action

Auteurs : Mohamed L. Ashour [Allemagne, Égypte] ; Michael Wink [Allemagne]

Source :

RBID : ISTEX:14401F5144E4DA6EF0ED9974CA76073E2106C7F9

English descriptors

Abstract

Objectives  Radix Bupleuri represents one of the most successful and widely used herbal drugs in Asia for treatment of many diseases over the past 2000 years. Thorough studies have been carried out on many species of this genus and have generated immense data about the chemical composition and corresponding biological activity of extracts and isolated secondary metabolites. In this work, we review the chemistry and pharmacology of the genus Bupleurum and explore the relationships between the pharmacological effects and the chemical composition of these drugs. Key findings  Early studies on the genus Bupleurum had focused only on the traditional uses of the plants in the treatment of inflammatory disorders and infectious diseases. After chemical profiling, several groups of secondary metabolites were characterized with relevant biological activity: triterpene saponins (saikosaponins), lignans, essential oils and polysaccharides. As a result, present interest is now focused on the bioactivity of the isolated triterpene saponins acting as immunomodulatory, anti‐inflammatory and antiviral agents, as well as on the observed ant‐iulcer activity of the polysaccharides and anti‐proliferative activity of different lignans. Many saikosaponins exhibited very potent anti‐inflammatory, hepatoprotective and immunomodulatory activities both in vivo and in vitro. Conclusions  Further investigations and screenings are required to explore other Bupleurum species, to evaluate the clinical safety and possible interactions with other drugs or herbs. Standardization of Bupleuri extracts is crucial for them being integrated into conventional medicine due to large chemical and biological variations between different species and varieties.

Url:
DOI: 10.1111/j.2042-7158.2010.01170.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Genus Bupleurum: a review of its phytochemistry, pharmacology and modes of action</title>
<author>
<name sortKey="Ashour, Mohamed L" sort="Ashour, Mohamed L" uniqKey="Ashour M" first="Mohamed L." last="Ashour">Mohamed L. Ashour</name>
</author>
<author>
<name sortKey="Wink, Michael" sort="Wink, Michael" uniqKey="Wink M" first="Michael" last="Wink">Michael Wink</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:14401F5144E4DA6EF0ED9974CA76073E2106C7F9</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1111/j.2042-7158.2010.01170.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-TGLWTHKH-F/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000E96</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000E96</idno>
<idno type="wicri:Area/Istex/Curation">000E69</idno>
<idno type="wicri:Area/Istex/Checkpoint">000627</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000627</idno>
<idno type="wicri:doubleKey">0022-3573:2011:Ashour M:genus:bupleurum:a</idno>
<idno type="wicri:Area/Main/Merge">001662</idno>
<idno type="wicri:Area/Main/Curation">001660</idno>
<idno type="wicri:Area/Main/Exploration">001660</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Genus Bupleurum: a review of its phytochemistry, pharmacology and modes of action</title>
<author>
<name sortKey="Ashour, Mohamed L" sort="Ashour, Mohamed L" uniqKey="Ashour M" first="Mohamed L." last="Ashour">Mohamed L. Ashour</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Pharmacy and Molecular Biotechnology, University Heidelberg, Im Neuenheimer Feld 364, Heidelberg</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Karlsruhe</region>
<settlement type="city">Heidelberg</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Égypte</country>
<wicri:regionArea>Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo</wicri:regionArea>
<wicri:noRegion>Cairo</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wink, Michael" sort="Wink, Michael" uniqKey="Wink M" first="Michael" last="Wink">Michael Wink</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Pharmacy and Molecular Biotechnology, University Heidelberg, Im Neuenheimer Feld 364, Heidelberg</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Karlsruhe</region>
<settlement type="city">Heidelberg</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Allemagne</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Journal of Pharmacy and Pharmacology</title>
<title level="j" type="alt">JOURNAL OF PHARMACY AND PHARMACOLOGY</title>
<idno type="ISSN">0022-3573</idno>
<idno type="eISSN">2042-7158</idno>
<imprint>
<biblScope unit="vol">63</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="305">305</biblScope>
<biblScope unit="page" to="321">321</biblScope>
<biblScope unit="page-count">17</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2011-03">2011-03</date>
</imprint>
<idno type="ISSN">0022-3573</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0022-3573</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Aerial part</term>
<term>Aerial parts</term>
<term>Aldehyde</term>
<term>Antifungal</term>
<term>Antimicrobial</term>
<term>Antiviral</term>
<term>Antiviral activity</term>
<term>Ashour</term>
<term>Avonoids</term>
<term>Biol pharm bull</term>
<term>Biological activity</term>
<term>Boca raton</term>
<term>Buddlejasaponin</term>
<term>Bupleuri</term>
<term>Bupleurum</term>
<term>Bupleurum chinense</term>
<term>Bupleurum falcatum</term>
<term>Bupleurum fruticosum</term>
<term>Bupleurum kaoi</term>
<term>Bupleurum salicifolium</term>
<term>Bupleurum scorzonerifolium</term>
<term>Bupleurum species</term>
<term>Chem</term>
<term>Chem pharm bull</term>
<term>Chemical structures</term>
<term>Chinense</term>
<term>Clinical applications</term>
<term>Coumarins</term>
<term>Cytotoxic</term>
<term>Cytotoxicity</term>
<term>Derivative</term>
<term>Different species</term>
<term>Essential oils</term>
<term>Falcatum</term>
<term>Fruticescens</term>
<term>Fruticosum</term>
<term>Genus</term>
<term>Genus bupleurum</term>
<term>Gibraltaricum</term>
<term>Glycoside</term>
<term>H3co</term>
<term>Hepatic</term>
<term>Hepatoprotective</term>
<term>Herpes</term>
<term>Immunomodulatory</term>
<term>Kaoi</term>
<term>Lett</term>
<term>Lignans</term>
<term>Macrophage</term>
<term>Major components</term>
<term>Marginatum</term>
<term>Medicinal</term>
<term>Medicinal plants</term>
<term>Michael wink</term>
<term>Mohamed</term>
<term>Och3</term>
<term>Oedema</term>
<term>Pge2</term>
<term>Pge2 production</term>
<term>Pharm</term>
<term>Pharm pharmacol</term>
<term>Pharmacol</term>
<term>Pharmacological</term>
<term>Pharmacological activity</term>
<term>Pharmacology</term>
<term>Phenolic</term>
<term>Phenylpropanoids</term>
<term>Phytochemistry</term>
<term>Planta</term>
<term>Polyacetylenes</term>
<term>Polysaccharide</term>
<term>Protective effect</term>
<term>Radix</term>
<term>Recent study</term>
<term>Replication</term>
<term>Rigidum</term>
<term>Saikogenin</term>
<term>Saikosaponin</term>
<term>Saikosaponins</term>
<term>Salicifolium</term>
<term>Saponin</term>
<term>Scorzonerifolium</term>
<term>Secondary metabolite</term>
<term>Secondary metabolites</term>
<term>Sgot</term>
<term>Sgpt</term>
<term>Triterpene</term>
<term>Triterpene saponins</term>
<term>Wide range</term>
<term>World health organization</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Objectives  Radix Bupleuri represents one of the most successful and widely used herbal drugs in Asia for treatment of many diseases over the past 2000 years. Thorough studies have been carried out on many species of this genus and have generated immense data about the chemical composition and corresponding biological activity of extracts and isolated secondary metabolites. In this work, we review the chemistry and pharmacology of the genus Bupleurum and explore the relationships between the pharmacological effects and the chemical composition of these drugs. Key findings  Early studies on the genus Bupleurum had focused only on the traditional uses of the plants in the treatment of inflammatory disorders and infectious diseases. After chemical profiling, several groups of secondary metabolites were characterized with relevant biological activity: triterpene saponins (saikosaponins), lignans, essential oils and polysaccharides. As a result, present interest is now focused on the bioactivity of the isolated triterpene saponins acting as immunomodulatory, anti‐inflammatory and antiviral agents, as well as on the observed ant‐iulcer activity of the polysaccharides and anti‐proliferative activity of different lignans. Many saikosaponins exhibited very potent anti‐inflammatory, hepatoprotective and immunomodulatory activities both in vivo and in vitro. Conclusions  Further investigations and screenings are required to explore other Bupleurum species, to evaluate the clinical safety and possible interactions with other drugs or herbs. Standardization of Bupleuri extracts is crucial for them being integrated into conventional medicine due to large chemical and biological variations between different species and varieties.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>Égypte</li>
</country>
<region>
<li>Bade-Wurtemberg</li>
<li>District de Karlsruhe</li>
</region>
<settlement>
<li>Heidelberg</li>
</settlement>
</list>
<tree>
<country name="Allemagne">
<region name="Bade-Wurtemberg">
<name sortKey="Ashour, Mohamed L" sort="Ashour, Mohamed L" uniqKey="Ashour M" first="Mohamed L." last="Ashour">Mohamed L. Ashour</name>
</region>
<name sortKey="Wink, Michael" sort="Wink, Michael" uniqKey="Wink M" first="Michael" last="Wink">Michael Wink</name>
<name sortKey="Wink, Michael" sort="Wink, Michael" uniqKey="Wink M" first="Michael" last="Wink">Michael Wink</name>
</country>
<country name="Égypte">
<noRegion>
<name sortKey="Ashour, Mohamed L" sort="Ashour, Mohamed L" uniqKey="Ashour M" first="Mohamed L." last="Ashour">Mohamed L. Ashour</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001660 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001660 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:14401F5144E4DA6EF0ED9974CA76073E2106C7F9
   |texte=   Genus Bupleurum: a review of its phytochemistry, pharmacology and modes of action
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021